To examine their relationship more closely, we assessed their expression patterns across development and found that NUAK1 did not share the same dynamic expression pattern across development as NUAK2, nor did its expression correlate with glioma tumor grade or patient survival. This evidence concerns the gene NUAK2 and central nervous system cancer.